In-111 transferrin scintigraphy in cirrhosis with hypoalbuminemia: Evidence for protein-losing enteropathy in a small group of selected cases
Authors:
- 2 July 2012
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 47 (10) , 1247-1252
Abstract
Background. Hypoalbuminemia commonly observed in cirrhosis is considered to be mainly related to hepatocellular dysfunction. However, the correlation between the decrease in serum albumin and liver function is far from linear and arguments in favor of an additive role of protein-losing enteropathy have been brought by a few studies. Aim. To assess the potential role of protein-losing enteropathy in a group of patients with cirrhosis, portal hypertension, and hypoalbuminemia. Design and methods. Eleven patients with documented cirrhosis, portal hypertension, and a low serum albumin level compared to liver function underwent an 111In-transferrin scintigraphy. Results. Using this sensitive method of investigation, nine exhibited features suggestive of exudative enteropathy. Serum albumin level and digestive protein loss were even correlated (Pearson's coefficient = –0.529, one-sided p = 0.047). Protein loss were however not correlated with the degree of portal hypertension or with the extent of liver dysfunction evaluated by the aminopyrine breath test. Conclusions. Our preliminary data obtained in a small group of selected patients with cirrhosis, portal hypertension, and hypoalbuminemia indicate that protein-losing enteropathy may represent an appreciable and underestimated cause of hypoproteinemia.Keywords
This publication has 26 references indexed in Scilit:
- Reversal of Protein-Losing Enteropathy After Liver Transplantation in a Child with Idiopathic Familial Neonatal HepatitisLiver Transplantation, 2009
- Plasma Disappearance Rate of Indocyanine Green in Liver DysfunctionTransplantation Proceedings, 2006
- Is portal hypertension associated with protein‐losing enteropathy?Journal of Gastroenterology and Hepatology, 2005
- [1-13C] Breath Test of Galactose and Fructose for Quantitative Liver FunctionJournal of Surgical Research, 2001
- Hepatic Parenchymal Cell Volume and the Indocyanine Green Tolerance TestJournal of Surgical Research, 2000
- 13C-Phenylalanine and 13C-Methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver diseaseDigestive and Liver Disease, 2000
- Transjugular intrahepatic portosystemic shunt as a treatment for protein-losing enteropathy caused by portal hypertensionGastroenterology, 1996
- Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantationJournal of Hepatology, 1996
- Breath14CO2 after intravenous administration of [14C]aminopyrine in liver diseasesDigestive Diseases and Sciences, 1982
- Protein-Losing Enteropathy in Patients with Liver CirrhosisDigestion, 1969